Biotech

Law News
Categories
LTP Special Column (255) Fintech (36) AI (23) ESG (29) Capital Markets / M&A / Cross-Border Investment (260) General Corporate Affairs (170) Infrastructure Projects / Construction Laws (113) Intellectual Property (53) Competition Law (86) Biotech (42) Energy (16) Telecom / Media / Technology (57) Employment Law (135) Personal Data Protection (47) Arbitration / Litigation (347) Tax (59) Other Areas (234)

July 2024

Series Articles of the Regenerative Medicine Dual Legislation (2) – Analysis of the Conditional Approval System for Regenerative Medicine Product

Teresa Huang

Hannah Kuo

David Hung

June 2024

Taiwan's Legislative Yuan Passed the Regenerative Medicine Dual Legislation

Chung Teh Lee

Teresa Huang

Oli Wong

Hannah Kuo

David Hung

June 2024

Next-Generation Gene Sequencing Tests Are Officially Included in Taiwan's National Health Insurance Benefits Starting from May 1, 2024!

June 2024

Series Articles of the Regenerative Medicine Dual Legislation (1) – Taiwan's Legislative Yuan Passed the Regenerative Medicine Dual Legislation

Chung Teh Lee

Teresa Huang

Oli Wong

Hannah Kuo

David Hung

May 2024

Evolution of Taiwan Reporting Severe Adverse Reactions of Medicaments

January 2024

Overview of Key Biotech and Pharmaceutical Issues in Taiwan for 2023

December 2023

The Prohibition on Physicians Posting Medical Advertisements was declared Unconstitutional by the Taiwan Constitutional Court

August 2023

Streamlined Examination Process for Pharmaceutical Patent Term Extension (Taiwan)

January 2023

Draft Amendments to the Rules of Medical Diagnosis and Treatment by Telecommunications Pre-announced by the MOHW of Taiwan

November 2022

Draft "Restrictions on Investment by Medical Juridical Persons Under Article 35, Paragraph 1 of the Medical Care Act" Pre-announced by the MOHW
< 1 2 3 4 5 >

Tag Cloud